On Dec 06, major Wall Street analysts update their ratings for $DocuSign (DOCU.US)$, with price targets ranging from $87 to $124.
Morgan Stanley analyst Josh Baer maintains with a hold rating, and adjusts the target price from $62 to $97.
Citi analyst Tyler Radke maintains with a buy rating, and maintains the target price at $87.
Needham analyst Scott Berg maintains with a hold rating.
RBC Capital analyst Rishi Jaluria maintains with a hold rating, and adjusts the target price from $59 to $90.
William Blair analyst Jake Roberge maintains with a hold rating.
Furthermore, according to the comprehensive report, the opinions of $DocuSign (DOCU.US)$'s main analysts recently are as follows:
DocuSign is following its strategic plan effectively, displaying 'several encouraging trends' that led to strong performance in Q3 and positively surprising Q4 billings forecasts. The primary indicators and company discussions showed either stability or enhancements, and the significant rise in stock value and its current standing in the afterhours indicate that the optimistic future trajectory is already accounted for in the current share prices.
DocuSign showcased a robust quarter following two consecutive quarters of mixed outcomes, marked by a significant billings beat and the CEO expressing confidence in achieving a growth rate exceeding 10%. The company indicated that its core business is stabilizing, and noted a slight improvement in the operational environment, while issues previously attributed to 'deal timing' and challenging macroeconomic conditions were not mentioned.
DocuSign posted a 'very strong' third quarter, notably exceeding expectations and showing accelerating subscription revenue. The company signals various positive growth trends that continue to encourage optimism among investors.
DocuSign exhibited solid gains in FQ3, with improvements noted across revenue, margins, and billings. Notably, the growth rate in subscription revenue accelerated to 8% compared to 7% in the preceding quarter, and the Net Revenue Retention (NRR) also improved to 100%, indicating a potential turnaround from recent declines.
DocuSign's recent financial performance was characterized by a notable increase in both top line and billings growth, propelled by early renewals, stabilization in its core operations, and promising momentum in IAM. Despite significant stock price appreciation since fiscal Q2, it remains appealingly valued in comparison to its industry peers.
Here are the latest investment ratings and price targets for $DocuSign (DOCU.US)$ from 7 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
